Minamiguchi, K.; Nishiofuku, H.; Saito, N.; Sato, T.; Taiji, R.; Matsumoto, T.; Maeda, S.; Chanoki, Y.; Tachiiri, T.; Kunichika, H.;
et al. Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers 2023, 15, 1238.
https://doi.org/10.3390/cancers15041238
AMA Style
Minamiguchi K, Nishiofuku H, Saito N, Sato T, Taiji R, Matsumoto T, Maeda S, Chanoki Y, Tachiiri T, Kunichika H,
et al. Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers. 2023; 15(4):1238.
https://doi.org/10.3390/cancers15041238
Chicago/Turabian Style
Minamiguchi, Kiyoyuki, Hideyuki Nishiofuku, Natsuhiko Saito, Takeshi Sato, Ryosuke Taiji, Takeshi Matsumoto, Shinsaku Maeda, Yuto Chanoki, Tetsuya Tachiiri, Hideki Kunichika,
and et al. 2023. "Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma" Cancers 15, no. 4: 1238.
https://doi.org/10.3390/cancers15041238
APA Style
Minamiguchi, K., Nishiofuku, H., Saito, N., Sato, T., Taiji, R., Matsumoto, T., Maeda, S., Chanoki, Y., Tachiiri, T., Kunichika, H., Inoue, T., Marugami, N., & Tanaka, T.
(2023). Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers, 15(4), 1238.
https://doi.org/10.3390/cancers15041238
